AZN: Why AstraZeneca’s Current Dip Is a Buying Opportunity By: InvestorPlace September 15, 2015 at 02:00 AM EDT Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb Pfizer